Jacqueline holds a PhD in Molecular Virology and brings with her experience gained from over 25 years in the biopharma industry from a variety of roles including clinical development, strategic planning and operations and programme leadership. Jacqueline has a broad portfolio of experience, having worked in orphan and rare disease, NCEs/ biologics, gene therapy, device, phases I-IV, companion diagnostics and is currently Program Head at Alvotech, leading the development and commercialization of biosimilar medicines.
PIPMG Role: Jacqueline has been a member of the PIPMG Executive committee since 2016 and is involved in all areas of PIPMG activity.